Dextroamphetamine Study Including Healthy Children Will Be First Test For Pediatric Ethics Subcommittee
This article was originally published in The Pink Sheet Daily
Executive Summary
NIH study proposes single-dose administration to both children with attention deficit/hyperactivity disorder and healthy volunteers. Institutional Review Board requested special review from HHS after two divided votes.
You may also be interested in...
Attention Deficit Study In Healthy Children Can Proceed Under Certain Conditions, Cmte. Says
NIH proposal to administer dextroamphetamine to healthy children represents only a slightly greater than minimal risk to study participants, FDA's Pediatric Ethics Subcommittee says. The Pediatric Advisory Committee will review the recommendations Sept. 15.
Attention Deficit Study In Healthy Children Can Proceed Under Certain Conditions, Cmte. Says
NIH proposal to administer dextroamphetamine to healthy children represents only a slightly greater than minimal risk to study participants, FDA's Pediatric Ethics Subcommittee says. The Pediatric Advisory Committee will review the recommendations Sept. 15.
FDA Analysis Of Antidepressant Pediatric Suicidality Data To Be Reviewed Sept. 13-14
Joint meeting of Psychopharmacologic and newly formed Pediatric Advisory Committees will review analysis performed by expert group assembled by Columbia University. Future research needs in pediatric suicidality will also be addressed.